We analysed the mRNA levels corresponding to 12 600 transcripts in primary cultures of ovarian epithelial cells derived from nine normal ovaries and 21 epithelial ovarian carcinoma. The class distinction and hierarchical clustering of expression data revealed a clear distinction in gene expression between normal and carcinomaderived ovarian epithelial cells. Comparison of expression levels revealed 111 genes with mean expression values of 42.5-fold higher in carcinoma cells. Similarly, 62 genes were expressed at 42.5-fold higher levels in normal ovarian epithelial cells. For a few selected genes, we demonstrate that the pattern of differential expression observed in cultured epithelial cells is present in the normal ovaries and epithelial ovarian carcinoma. Use of cultured epithelial cells represents a novel strategy to study gene expression in a cell-type specific manner.
Introduction
Approximately 23 000 women will be diagnosed with epithelial ovarian carcinoma (EOC) each year, and less than half of them will be alive at 5 years (Greenlee et al., 2000) . If diagnosed early, the disease is curable with surgical resection and adjuvant chemotherapy. However, because of absence of specific symptoms in early stages of the disease, two-thirds of patients are diagnosed with advanced disease (Young et al., 2001) . The only serologic marker in use for EOC is CA125, which is helpful for monitoring disease progression, but lacks the specificity to be useful in screening (Jacobs and Bast, 1989) . Recent studies have shown that the patterns of proteins in serum can provide a discriminatory power to correctly diagnose early stage EOC (Petricoin et al., 2002) . These proteomics assays, either alone or in conjunction with other screening tests, may improve early detection of EOC.
EOC originates from the single layer of epithelial cells covering the surface of the ovaries (Bell and Scully, 1994) . Different histological patterns can be identified, sometimes intermixed within the same tumor. The serous papillary subtype is the most common, while mucinous, endometroid, and clear cell subtypes represent less commonly encountered variants (Young et al., 2001) . A related entity, primary peritoneal carcinomatosis, arises from extraovarian sites in the peritoneum and has a clinical behavior that mirrors advanced stage ovarian cancer. It often has Mu¨llerian features, reflecting a common embryological origin in the celomic epithelium that gives rise to both peritoneal lining and ovarian surface epithelium. It has been hypothesized that EOC and primary peritoneal carcinomatosis arise from either the mesothelial lining of the ovarian surface or components of the secondary Mu¨llerian system, which include paratubal cysts, rete ovarii, endosalpingiosis, endometriosis, and endomucinosis (Dubeau, 1999) .
The molecular changes associated with EOC include mutations in the BRCA 1 and 2 genes, alterations of p53, and amplification of HER2/neu, PIK3CA, AKT2, and myc (Cheng et al., 1992; Foster et al., 1996; Marks et al., 1991; Shayesteh et al., 1999; Slamon et al., 1989; Takahashi et al., 1995) . In addition, a number of genes have been reported to be either upor down-regulated in EOC (Hough et al., 2000; Ismail et al., 2000; Mok et al., 1994; Ono et al., 2000; Schummer et al., 1999; Welsh et al., 2001) . Gene expression comparison of EOC to the normal ovarian epithelial counterpart has been difficult to perform, as the epithelial layer of the ovaries comprises 51% of the mass of the organ. This problem is further confounded by the lack of premalignant changes in the ovaries and the heterogeneity of the disease. To focus on cancer cell specific molecule changes, an ovarian cancer model based on primary cells cultured from the normal ovaries and EOC, which eliminates signals from non-malignant cells intermixed within tumors (e.g., stromal cells, endothelial cells, immune cells), has been used (Ismail et al., 2000; Mok et al., 1994) .
We characterize gene expression in EOC-derived epithelial cells (CSOC, Cedar Sinai Ovarian Cancer) and normal ovarian epithelial cells (HOSE, Human Ovarian Surface Epithelia) using Affymetrix U95Av2 Genechips. The analysis of expression data revealed a clear distinction between CSOC and HOSE. For a limited number of selected genes, the differential expression was also demonstrated in EOC. We suggest that primary epithelial cells cultured from tumors can be used to study gene expression in a cell-type specific manner to complement gene expression analysis based on tumors.
Results

Primary cell cultures of HOSE and CSOC
Nine HOSE and 21 CSOC cultures were used for analysis. These primary cells display a limited life span of 5 -12 passages for HOSE and a slightly extended 10 -15 passages for CSOC. The characteristics of the CSOC cultures and the EOC they were derived from are detailed in Tables 1 and 2 . While cultures of varying passage numbers were used, no apparent correlation between the passage number and the proximity of samples based on the gene expression pattern was observed in the hierarchical clustering analysis (Figure 2 ).
Gene expression-based distinction of HOSE and CSOC
RNA from primary ovarian epithelial cultures was used to determine expression levels for 12 600 transcripts using the Affymetrix U95Av2 Genechips and gene expression differences between the HOSE and CSOC samples were compared to differences between randomly generated groups of equivalent sizes. This 'neighborhood analysis' (Golub et al., 1999) allows one to establish whether the correlation of observed gene expression in HOSE and CSOC samples to the normal/ malignant classification is stronger than would be expected by chance (see Materials and methods). Based on this analysis, 50.1% of the random classifications had more genes with significant expression differences than the normal/malignant classification (Figure 1) . Thus, the differences between HOSE and CSOC are reflected in their overall gene expression patterns.
Genes differentially expressed in HOSE and CSOC
When the two groups (HOSE and CSOC) were compared, 2176 genes had levels of difference in expression that reach statistical significance, based on the two-tailed Student's t-test (P50.05). Within this group, there were 111 genes (0.9% of 12 600) with 42.5-fold higher levels of expression in the cancer cells and 62 genes (0.5% of 12 600) with 42.5-fold higher levels of expression in the normal cells. Tables 3 and 4 list the top 30 genes in each category with their mean expression levels and P-values.
Genes previously reported to be up-regulated in ovarian cancer (e.g. PAI2, ALP, COL11A1, OSF2, PDGFRa) and novel genes not previously associated with EOC (e.g., TGM2, ACLP, RAGE3, TSG14, Wnt5a frizzled 7) were among the genes over expressed in CSOC. Genes strongly correlated with the HOSE phenotype were equally diverse. StAR, adipophilin, and fibulin2 encode proteins expressed in ovarian tissue. Other HOSE-specific genes reflect the epithelial nature of the HOSE (e.g., PEM, plakophilin, merocin, Muc1).
Hierarchical clustering of HOSE and CSOC gene expression
To visualize the gene expression distinction between HOSE and CSOC, we used hierarchical clustering (Figure 2 ). This analysis was carried out using *1500 genes with significant variation across samples (see Materials and methods). Whereas the 'neighborhood analysis' sorts genes by their degree of correlation to the normal/malignant classification, the hierarchical clustering algorithm groups experimental samples according to the overall similarity in their gene expression pattern. The dendogram pictured in Figure  2b illustrates the main segregation of the gene expression patterns. The majority (26 out of 30) samples segregated correctly to normal and malignant clusters, according to their original tissue diagnosis. Three CSOC samples (C889, C858 and C918) clustered on a sub branch within the HOSE group, while one HOSE sample (H263) clustered with the CSOC samples. The only distinctive feature of H263 culture was that it was derived from an ovary with benign cysts and stromal hyperplasia ( Table 2 ).
The main subgroups of genes driving the separation of HOSE and CSOC are shown in Figure 2c -f. For presentation purpose only a segment of each cluster is shown. As expected, some of the genes recognized here included the genes that were also selected based on the Student's t-test as being preferentially expressed in HOSE or CSOC. One group of genes separating out the HOSE cluster from the rest of samples is comprised of genes that are highly expressed in the normal cells (e.g. gap junction protein, carbonic anhydrase IX and XII, stanniocalcin, fibulin 2, plakophilin) ( Figure 2c ). Also included in this cluster are two potential tumor suppressor genes, Mxi1 and DOC1 (Lee and Ziff, 1999; Mok et al., 1994) .
Within the CSOC division, there were additional subgroups. Statistically significant distinctions among different subgroups could not be established, but we note several 'molecular portraits'. For instance, a subgroup of seven samples (C843, C846, C839, C824, C823, C834 and C817) was characterized by intense expression of the genes encoding proteasome-related proteins, nm23, placental protein 15, and karyopherin alpha 6 (Figure 2d ). The second subgroup of four samples (C824, C823, C834 and C817) clustered together because of high expression levels of genes associated with cell proliferation (e.g. CDC2, cyclinA2, cyclinB1, CDC28 protein kinase 2, CDC20) ( Figure 2e ). This fraction of samples may represent an actively cycling group of tumor cells with more aggressive behavior. The third subgroup of five samples (C886, C844, C917, C866 and C798) clustered together mainly due to higher expression levels of genes encoding Figure 1 The gene expression differences between HOSE and CSOC samples are statistically significant. The number of genes with P-values less than various threshold levels (Materials and methods) were calculated for the normal/malignant classification and plotted. Random groupings were also generated and tested. The median and various confidence levels for these random groupings are also plotted. A confidence level of 1%, for example, indicates that 51% of the random groupings had a higher number of genes that were differentially expressed with P-values below the indicated P-value threshold extracellular matrix proteins and cell adhesion receptors (e.g. OSF2, biglycan, procollagen I N-proteinase, integrin b1 like protein, band 7.2 protein, lumican) (Figure 2f ).
Validation of cancer cell-specific gene expression
Four genes (Wnt5a, OSF2, PAI2 and TGM2) were selected for RT -PCR analysis. RNA from three HOSE and seven CSOC samples used in the array , and 'ECM/cell adhesion group' (g), based on the predominance of particular type of genes in each group. Commonly used alias of the gene name is provided with the corresponding UniGene number (http://www.ncbi.nlm.nih.gov/UniGene/). The scale at the bottom shows the relationships between color saturation and the normalized gene expression levels analysis were randomly chosen and used as templates.
There was a rough correlation between the intensity of the bands and the gene expression levels from the oligonucleotide array studies when the RT -PCR products after a limited, and presumably non-saturating, number of amplification cycles were analysed by gel electrophoresis (Figure 3 ). The expression of Wnt5a, OSF2, PDGF-a receptor (PDGFRa), and n-chimerin in ovarian tissue was also examined by RT -PCR. A qualitative difference in the levels of RT -PCR products in tumors compared to the normal ovaries was readily visible for each of four genes (Figure 4a ). In the case of PDGFRa and OSF2, which were not detected in the normal ovaries, RT -PCR products were detected in 10/15 (for PDGFRa) and 13/15 (for OSF2) ovarian tumors. The different sizes RT -PCR products in OSF2 are due to alternative splicing at the 3' end of the coding region (Horiuchi et al., 1999) . Similarly, higher levels of RT -PCR products were detected for Wnt5a and nchimerin in eight out of 15 and nine out of 15 tumor samples, respectively. RT -PCR products were also demonstrated for TGM2 in tumor samples, but not in the normal ovaries (data not shown). RT -PCR for PAI2 gave similar levels of products in normal ovaries and tumors (data not shown).
For OSF2 and TGM2, we examined protein expression in ovarian tissues by immunoblot. Polyclonal rabbit anti-OSF2 antibodies detected a group of proteins migrating at *90 kD six out of 10 tumors (Figure 4b) . In three normal ovaries tested, OSF2 Gene expression levels as determined by microarrays are shown expression was negligible. TGM2 was expressed in eight out of 10 tumors, but not in the normal ovaries. In three tumors (T1354, T1357 and T1475), an additional anti-TGM2 immunoreactive band migrating at *65 kD is seen. This faster migrating band may represent the previously reported TGM2 isoform (Fraij et al., 1992) .
OSF2 immunohistochemistry (IHC)
The OSF2 expression in ovarian tissue was also examined by IHC (Table 5 ). In serous papillary carcinoma samples, eight out of 26 displayed intermediate to strong (2+ to 3+) OSF2 staining. In some tumors, the OSF2 staining was heterogeneous, with areas corresponding to invasive foci and regions with poor histological differentiation displaying a stronger staining. OSF2 staining was weak in 12 and absent in the remaining six tumor samples. In serous borderline tumors, only two of seven samples stained weakly (1+) for OSF2 in *10% of cells. Eight of the nine normal ovaries displayed no OSF2 staining. One normal ovarian tissue showed weak staining (1+, in *20% of cells) in an area corresponding to benign cystic proliferation. Representative photographs of OSF2 staining in ovarian tissue are shown in Figure 5 .
Discussion
We utilized an ovarian cancer model that is based on in vitro expansion of normal and malignant ovarian epithelial cells (Karlan et al., 1995; Mok et al., 1994) . In this model, all cultured cells are epithelial, based on positive staining for cytokeratin, and grossly uniform (Ismail et al., 2000; Karlan et al., 1995) . Reliance on cultured cells introduces potential problems related to the secondary gene expression changes stemming from in vitro selection and variability in culture conditions. Some of the gene expression variation seen in different HOSE and CSOC samples and incorrect clustering of three CSOC and one HOSE samples may reflect this in vitro expansion bias (see Figure 2) . However, these problems are offset by the fact that the use of expanded primary cultures is more likely to reveal gene expression changes that are cancer cell specific. Two lines of evidence indicate that distinct cells are cultured from the EOC than the normal ovary. First, when the gene expression levels were sorted by degree of their correlation to class distinction (i.e., CSOC vs HOSE) by the 'neighborhood analysis' method, there was an unusually high density of genes that followed the idealized pattern of this class distinction, as compared to equivalent random patterns. Second, the hierarchical clustering algorithm uncovered a clear GeneBank accession numbers and the corresponding description of the gene is provided for each U95Av2 Affymetrix probe sets. The fold difference between CSOC and HOSE samples, P-value for differential expression, mean hybridization signal intensity in CSOC and HOSE samples are included separation between the normal cells from malignant cells. This separation represents the main division of our clustering tree, followed by smaller subdivisions distinguishing separate fractions within the CSOC sample group. These findings, together with the previous observation that CSOC cells, but not HOSE cells, contain chromosome abnormalities (Ismail et al., 2000) support the use of cultured epithelial cells in gene expression studies.
The gene expression profiles of three CSOC (C889, C858, and C918) and one HOSE (H263) were sufficiently different, resulting in their clustering away from the main divisions of the dendogram (Figure 2 ).
There were no consistent features of the three CSOC cultures, in the histology of the tumors which there were derived from, immunoreactivity to keratin, vimentin, or Factor VIII, or culture passage number, that would account for the differences in gene expression pattern. It is possible that a subtle, unrecognized, variation in the handling of the cultured cells might have skewed the gene expression. Another possibility is that the differences in their gene expression pattern reflect their distinct cellular characteristics. In this regard, it is interesting that H263 were cultured from an ovary with stromal hyperplasia and that the cultured cells had a much stronger immunoreactivity to cytokeratin than the other HOSE cultures ( Table 2 ).
The list of differentially expressed genes includes genes that have previously been associated with the neoplastic process as well as those that have not been recognized as transformation related genes in ovarian or other human cancers. Among these, OSF2 (also known as periostin), which encodes a secreted protein related to the axon guidance molecule fasciclin-1 of insect (Takeshita et al., 1993) , ranks high (P=0.00002). The frequency of OSF2 positivity in CSOC cultures was *70% by Northern blot analysis in our previous study (Ismail et al., 2000) , which correlates closely with the observed frequency of OSF2 staining in tumors (77%, 31% intermediate to strong and 46% weak staining). In tumors, anti-OSF2 antibodies stained intensely in the cytoplasm of the cancer cells ( Figure  5 ), indicating that the cancer cells express OSF2. Two recent studies have reported that the serum OSF2 levels are elevated in lung cancer and thymoma patients (Sasaki et al., 2001a,b) , raising the possibility that the OSF2 expression status may provide a prognostic or predictive information for EOC.
Other genes of potential interest include PDGFRa, Wnt5a TGM2, and n-chimerin. Previous studies have shown PDGF and/or PDGFRa are over-expressed in EOC, suggesting a functional role of PDGF via autocrine growth stimulation (Henriksen et al., 1993; Link et al., 1996) . The availability of tyrosine kinase inhibitors with specificity towards PDGF receptors affords an opportunity to test the role of PDGF axis in the pathogenesis of EOC. The Wnt genes encode a family of secreted growth factors critical for embryonic pattern formation and cell lineage differentiation (Cadigan and Nusse, 1997) . While Wnt5a protein is not known to be transforming, it is implicated in the regulation of progenitor cell proliferation and upregulated in breast cancer (Lejeune et al., 1995; Yamaguchi et al., 1999) . TGM2 is a GTP-binding protein that participates in protein transamidation and has been suggested to play a role in Rho signaling and cell cycle and apoptosis (Antonyak et al., 2001; Nanda et al., 2001; Singh et al., 2001) . N-chimerin is a GTPase-activating protein for Rac1 and Cdc42Hs and may regulate cell motility by inducing the formation of lamellipodia (Kozma et al., 1996) .
Analysis of genes with stronger expression in HOSE offers insight into genes that may play a permissive role Lee and Ziff, 1999) . Other genes with strong signal in HOSE include plakophilin, stanniocalcin, adipophilin, BST2, StAR, PACE4, prostacyclin synthetase and Muc1. These genes are expressed in a tissue-restricted manner and may represent differentiation specific genes (Heid et al., 1998; Ishikawa et al., 1995; Mains et al., 1997; Mertens et al., 1996; Stasko and Wagner, 2001) . The downregulation of these genes may reflect cellular dedifferentiation associated with neoplastic transformation. We demonstrate that cultured epithelial cells provide a unique method for studying gene expression in a cellautonomous manner. Genes that are differentially expressed in a cancer cell-specific manner may help us understand the pathogenesis of EOC and could be targeted for the development of diagnostic or therapeutic tools.
Materials and methods
Primary ovarian epithelial cell cultures
Primary cultures of ovarian surface epithelial cells were initiated by explanting ovarian surface scrapings or dissected ovarian surface fragments (Auersperg et al., 1994; Ismail et al., 2000; Karlan et al., 1995) . Their epithelial nature was verified by IHC using antibodies against cytokeratin 
Oligonucleotide arrays
Total RNA was extracted from each culture using RNA STAT-60 reagent (Tel-Test Inc, Friendswood, TX, USA) and purified using the RNeasy Mini Kit (Qiagen Inc, Valencia, CA, USA). Double-stranded cDNA was synthesized using the HPLC purified T7-(dT)24 primer (Genset Corp, La Jolla, CA, USA) and cDNA Superscript Choice System (Gibco BRL, Carlsbad, CA, USA). Biotinylated cRNA probe was obtained using the Bioarray High Yield RNA Transcript Labeling Kit (Enzo Biochem Inc, Farmingdale, NY, USA). Fifteen mg of labeled cRNA was incubated in 40 mM Trisacetate, pH 8.1, 0.1 M potassium acetate, 30 mM magnesium acetate at 948C for 35 min and hybridized to U95Av2 Genechips (Affymetrix, Santa Clara, CA, USA). The expression level for each probe set was calculated using the Affymetrix Microarray Suite (version 4.0.1) (Affymetrix). Briefly, the expression level was based on an average of differences between the perfect match-mismatch probe pairs for each gene. The values of the perfect match -mismatch pairs outside three standard deviations from the mean intensity (i.e. Affymetrix parameter STP set three) were discarded as outliers. The intensities across different chips were normalized to a target intensity of 2500 using global normalization scaling. All values below the intensity of the background (300) across experiments were set equal to the background.
Data analysis
All genes were ranked by their probability of being significantly differentially expressed between the two sample types as determined using the Student's t-test. The fold change in the mean of each gene between the normal and malignant samples was also calculated. The 'neighborhood analysis' (Golub et al., 1999) was carried out using the same measure of differential expression as used in the Student's t-test,
s where m i , s i and n i are the mean, standard deviation and number of samples, respectively, of sample group i. P-values were then calculated based on the t-value (Press et al., 1992) . Random groupings (or permutations) of the samples were generated with one group containing the same number of samples as the original normal group, and the other containing the same number as the original malignant group. Random groupings were performed 10 000 times, and the mean and various significance levels for the number of genes with P-values greater than a threshold level were determined. The hierarchical clustering analysis (Eisen et al., 1998) was carried out using *1500 genes with significant variation across samples (as defined by a standard deviation (s) greater than 1000 and a coefficient of variation (s/m) greater than 0.3) and an Affymetrix 'present' call in at least half of the experiments. We used the Pearson coefficient of correlation as a measure of linkage among genes and respectively, samples. No transformation of the data was performed prior to clustering.
RT -PCR
The Superscript II system was used for reverse transcription, starting with 5 mg of total RNA and oligo-dT primer in a 20 ml reaction volume. The RT product (0.5 ml) and primers (50 ng) were heated at 948C for 90 s, followed by 27 -30 rounds of amplification (30 s denaturing at 948C, 30 s annealing at 608C, 30 s extension at 728C, followed by a final extension at 728C for 10 min). The primer sequences are: Wnt5a (forward (F): GCAACAAGGTAATTGCGTGC-CATTCAG, reverse (R): CAGTGATACGCTGCAACA-CCTCTGTG), TGM2 (F: GCTGTGAGGAATGCTCT-GCAG, R: GCAACTAGTAGGTGCTTCACAATGGTG), PAI2 (F: GAACTCAGATCCATTCTGAGAAGC, R: GC-AATTCTGAGGCACACAGCTCATC), OSF2 (F: GTGGT-AGCACCTTCAAAGAAATC, R: CCTGAGAACGACC-TTCCCTTAATCG), PDGFRa: (F: CACTCTCTTCAGA-GGTCTGCGAG, R: CACTCTCTTCAGAGGTCTGCG-AG), n-chimerin (F: ATGAGATCTCCAGAACTAGACG, R: GCTAATCATGCAATAGCTTGAG), GAPDH (F: GA-TTCCACCCATGGCAAATTCC, R: CACGTTGGCAGT-GGGGAC), and b-actin (F: TGCGTGACATTAAGGA-GAAG, R: GCTCGTAGCTCTTCTCCA).
Immunoblotting
Frozen tissues were homogenized in a buffer containing 25 mM HEPES, pH 7.5, 150 mM sodium chloride, 12.5 mM EDTA, 1 mM DTT, 1% Triton X-100, 10% glycerol, and 1 mM each of aprotinin, leupeptin and phenylmethylsulfonyl fluoride. Twenty mg of protein in sample buffer were separated on a 7.5% SDS gel, transferred to a nitrocellulose membrane, and blotted with rabbit anti-OSF2 serum (1 : 3000), rabbit anti-TGM2 antibody (5 mg per ml; Neomarkers, Fremont, CA, USA), or anti-b actin antibody (1 : 10 000; Sigma, St Louis, MO, USA). A horseradish peroxidase-conjugated anti-rabbit antibody (1 : 10 000; Transduction Laboratories, Lexington, KY, USA) was used as the secondary and protein bands were visualized by chemiluminescence (Pierce, Rockford, IL, USA). Rabbit anti-OSF2 serum was generated using a bacterially produced 784 aa OSF2 derived from EST clone ID:1091416 (GenBank Accession AA599197) as the immunogen.
IHC
Paraffin-embedded ovarian tissue slides were processed for antigen retrieval by heating in 10 mM sodium citrate, pH 6.0 at 958C for 25 min. The slides were blocked with 3% goat serum in 25 mM Tris, 150 mM sodium chloride, pH 7.5 for 30 min and then incubated with anti-OSF2 serum (1 : 1200) for 30 min. Subsequent substrate-chromogen development was carried out using a DAKO En Vision TM +System, Peroxidase (DAB) kit (DAKO, Carpinteria, CA, USA), following the manufacturer's instructions. Staining was graded from 0 (no staining) to 3+ (strong staining) by a board certified pathologist (J Rao).
